{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T21:56:40Z","timestamp":1778018200091,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.neuropharm.2007.08.005","type":"journal-article","created":{"date-parts":[[2007,8,16]],"date-time":"2007-08-16T16:53:08Z","timestamp":1187283188000},"page":"763-770","source":"Crossref","is-referenced-by-count":36,"title":["Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice"],"prefix":"10.1016","volume":"53","author":[{"given":"Shervin","family":"Gholizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Shafaroodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Bahremand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Sharifzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2007.08.005_bib1","series-title":"Marihuana: The First Twelve Thousands Years","author":"Abel","year":"1980"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib2","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1124\/jpet.105.100354","article-title":"Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus","volume":"317","author":"Blair","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib3","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0022-3565(24)37876-0","article-title":"Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses","volume":"287","author":"Bonhaus","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib4","first-page":"461","article-title":"Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures","volume":"38","author":"Chen","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00421539","article-title":"Anticonvulsant effects of cannabinoids in mice: drug interactions within cannabinoids and cannabinoid interactions with phenytoin","volume":"37","author":"Chesher","year":"1974","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.1992.tb25954.x","article-title":"Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain","volume":"654","author":"Childers","year":"1992","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib7","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1073\/pnas.92.23.10540","article-title":"Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance\/dependence during chronic co-treatment","volume":"92","author":"Crain","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3959(99)00223-7","article-title":"Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance\/dependence liability","volume":"84","author":"Crain","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib51","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0885-3924(03)00139-8","article-title":"Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone","volume":"25","author":"Cruciani","year":"2003","journal-title":"J. Pain Symptom Manage"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuroscience.2003.08.015","article-title":"Comparative fos immunoreactivity in the brain after forebrain, brainstem, or combined seizures induced by electroshock, pentylenetetrazol, focally induced and audiogenic seizures in rats","volume":"123","author":"Eells","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3565(24)37189-7","article-title":"LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation","volume":"284","author":"Felder","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004691-199204010-00007","article-title":"Subcortical structures and pathways involved in convulsive seizure generation","volume":"9","author":"Gale","year":"1992","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib49","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib14","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1211\/0022357011777891","article-title":"Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms","volume":"53","author":"Hayase","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib15","series-title":"The Emperor Wears No Clothes: The Authoritative Historical Record of Cannabis and the Conspiracy Against Marijuana","author":"Herer","year":"1998"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib16","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-3565(24)38289-8","article-title":"Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)","volume":"289","author":"Hillard","year":"1999","journal-title":"Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(02)02533-7","article-title":"Anticonvulsant effects of cyclosporin A on pentylenetetrazole-induced seizure and kindling: modulation by nitricoxidergic system","volume":"939","author":"Homayoun","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.neuroscience.2004.08.029","article-title":"Ultra-low dose naltrexone potentiates the anticonvulsant effect of low dose morphine on clonic seizures","volume":"129","author":"Honar","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.pa.35.040195.003135","article-title":"Pharmacology of cannabinoid receptors","volume":"35","author":"Howlett","year":"1995","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib20","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1016\/0006-2952(89)90628-X","article-title":"Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies","volume":"38","author":"Howlett","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuropharm.2004.07.030","article-title":"Cannabinoid physiology and pharmacology: 30 years of progress","volume":"47","author":"Howlett","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0028-3908(89)90166-4","article-title":"Pentylenetetrazol kindling in mice","volume":"28","author":"Karler","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1528-1157.2001.0420s4007.x","article-title":"Animal models used in the screening of antiepileptic drugs","volume":"42","author":"Kupferberg","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib52","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1528-1157.1986.tb03573.x","article-title":"Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action","volume":"27","author":"Leach","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-1211(88)90054-X","article-title":"Which animal models should be used in the search for a new antiepileptic drugs? A proposal based on experimental and clinical considerations","volume":"2","author":"L\u00f6scher","year":"1988","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs: III, Pentylenetetrazole seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib27","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1073\/pnas.89.9.3825","article-title":"Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells","volume":"89","author":"Mackie","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(99)01339-5","article-title":"Pharmacological and biochemical interactions between opioids and cannabinoids","volume":"20","author":"Manzanares","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0009-3084(02)00153-6","article-title":"CB1 cannabinoid receptor-G protein association: a possible mechanism for differential signalling","volume":"121","author":"Mukhopadhyay","year":"2002","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00008877-200512000-00001","article-title":"Ultra-low dose naltrexone enhances cannabinoid-induced antinociception","volume":"16","author":"Paquette","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib50","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/jpet.300.2.588","article-title":"Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats","volume":"300","author":"Powell","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.bjp.0706661","article-title":"Differential activation of G-proteins by \u03bc-opioid receptor agonists","volume":"147","author":"Saidak","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/ebeh.2001.0193","article-title":"Overview of the current animal models for human seizure and epileptic disorders","volume":"2","author":"Sarkisian","year":"2001","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(97)00197-2","article-title":"Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuates tolerance\/dependence in mice","volume":"757","author":"Shen","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib37","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1523\/JNEUROSCI.16-14-04322.1996","article-title":"Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures","volume":"16","author":"Shen","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib38","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neuropharm.2004.04.011","article-title":"The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice","volume":"47","author":"Shafaroodi","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eplepsyres.2007.04.005","article-title":"Role of ATP-sensitive potassium channels in the effect of morphine on pentylenetetrazole-induced seizure threshold in mice","volume":"75","author":"Shafaroodi","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib40","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1212\/WNL.57.11.2108","article-title":"Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study","volume":"57","author":"Sieradzan","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib41","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1248\/cpb.46.1462","article-title":"Synthesis and pharmacological activities in mice of halogenated delta 9-tetrahydrocannabinol derivatives","volume":"46","author":"Usami","year":"1998","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.neuropharm.2007.08.005_bib42","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1046\/j.0953-816x.2001.01558.x","article-title":"Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal\u00a0syndrome without change in rewarding effect","volume":"13","author":"Valverde","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.103.051920","article-title":"The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy","volume":"307","author":"Wallace","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(01)01243-2","article-title":"Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects","volume":"428","author":"Wallace","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(02)02331-2","article-title":"Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity","volume":"452","author":"Wallace","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1152\/physrev.2001.81.1.299","article-title":"Cellular and synaptic adaptations mediating opioid dependence","volume":"81","author":"Williams","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2007.08.005_bib46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0006-8993(00)02096-5","article-title":"Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse","volume":"862","author":"Yajima","year":"2000","journal-title":"Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807002511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807002511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T11:56:50Z","timestamp":1737374210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390807002511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0028390807002511"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.08.005","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}